ES2174287T3 - Empleo de las amidas del acido gamma-hidroxibutarico en el tratamiento de drogadicciones y en particular del alcoholismo. - Google Patents
Empleo de las amidas del acido gamma-hidroxibutarico en el tratamiento de drogadicciones y en particular del alcoholismo.Info
- Publication number
- ES2174287T3 ES2174287T3 ES97941921T ES97941921T ES2174287T3 ES 2174287 T3 ES2174287 T3 ES 2174287T3 ES 97941921 T ES97941921 T ES 97941921T ES 97941921 T ES97941921 T ES 97941921T ES 2174287 T3 ES2174287 T3 ES 2174287T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- amidas
- acid
- alcoholism
- hydroxibutaric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000007848 Alcoholism Diseases 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title abstract 2
- 201000007930 alcohol dependence Diseases 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 235000013334 alcoholic beverage Nutrition 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- 229960005181 morphine Drugs 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 208000011117 substance-related disease Diseases 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE AMIDAS DE ACIDO GA - HIDROXIBUTIRICO, DENOMINADAS AQUI GHB, EN EL TRATAMIENTO DE LA ADICCION A DROGAS COMO LA HEROINA, LA MORFINA Y A SUSTANCIAS PSICOACTIVAS, Y EN EL TRATAMIENTO DEL ALCOHOLISMO, MAS ESPECIALMENTE PARA DISMINUIR EL DESEO CRONICO DE LOS ALCOHOLICOS Y SU HABITO DE CONSUMO DE BEBIDAS ALCOHOLICAS, Y EN EL TRATAMIENTO DEL SINDROME DE ABSTINENCIA DEL ALCOHOL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT96MI001732A IT1283782B1 (it) | 1996-08-09 | 1996-08-09 | Uso di ammidi dell'acido gamma-idrossibutirrico nel trattamento di tossicodipendenze,ed in particolare sell'alcolismo |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2174287T3 true ES2174287T3 (es) | 2002-11-01 |
Family
ID=11374795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97941921T Expired - Lifetime ES2174287T3 (es) | 1996-08-09 | 1997-08-07 | Empleo de las amidas del acido gamma-hidroxibutarico en el tratamiento de drogadicciones y en particular del alcoholismo. |
Country Status (13)
Country | Link |
---|---|
US (2) | US6436998B1 (es) |
EP (1) | EP0932597B1 (es) |
JP (1) | JP4259615B2 (es) |
AT (1) | ATE215065T1 (es) |
AU (1) | AU4379097A (es) |
CA (1) | CA2263328C (es) |
DE (1) | DE69711411T2 (es) |
DK (1) | DK0932597T3 (es) |
ES (1) | ES2174287T3 (es) |
HU (1) | HU228595B1 (es) |
IT (1) | IT1283782B1 (es) |
PT (1) | PT932597E (es) |
WO (1) | WO1998006690A1 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000038672A2 (en) | 1998-12-23 | 2000-07-06 | Orphan Medical, Inc. | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
FR2827859B1 (fr) | 2001-07-30 | 2005-09-23 | Lipha | Derives 4-(arylthio) - ou 4-(heteroarylthio) -butyrique dans la preparation de medicaments destines au traitement du diabete |
AU2003295393A1 (en) * | 2002-11-01 | 2004-06-07 | Baylor Research Institute | Ghb treatment methods |
US7838556B2 (en) * | 2006-02-21 | 2010-11-23 | University Of Maryland, Baltimore | Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligands |
EP2062875A1 (en) * | 2007-11-13 | 2009-05-27 | LABORATORIO FARMACEUTICO C.T. S.r.l. | New polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide |
US8778398B2 (en) * | 2008-11-04 | 2014-07-15 | Jazz Pharmaceuticals, Inc. | Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
US8771735B2 (en) * | 2008-11-04 | 2014-07-08 | Jazz Pharmaceuticals, Inc. | Immediate release dosage forms of sodium oxybate |
AU2011232408B2 (en) | 2010-03-24 | 2015-07-30 | Jazz Pharmaceuticals, Inc. | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
US8591922B1 (en) | 2012-12-14 | 2013-11-26 | Jazz Pharmacuticals, Inc. | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
ITMI20132041A1 (it) * | 2013-12-06 | 2015-06-07 | Ct Lab Farm Srl | Derivati dell'acido gamma-idrossibutirrico, loro preparazione e loro uso medico. |
US10398662B1 (en) | 2015-02-18 | 2019-09-03 | Jazz Pharma Ireland Limited | GHB formulation and method for its manufacture |
ITUB20152860A1 (it) * | 2015-08-04 | 2017-02-04 | Laboratorio Farm C T S R L | Selezionata amide dell?acido ?-idrossibutirrico e suoi usi nel trattamento dell?abuso da alcool |
ITUA20164040A1 (it) * | 2016-06-01 | 2017-12-01 | Laboratorio Farm C T S R L | Procedimento per la preparazione di polimorfo a |
US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
US20180263936A1 (en) | 2017-03-17 | 2018-09-20 | Jazz Pharmaceuticals Ireland Limited | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
CA3115122A1 (en) | 2018-11-19 | 2020-05-28 | Jazz Pharmaceuticals Ireland Limited | Alcohol-resistant drug formulations |
JP2022522270A (ja) | 2019-03-01 | 2022-04-15 | フラメル アイルランド リミテッド | 食事摂取状態における改善された薬物動態を有するガンマ-ヒドロキシ酪酸塩組成物 |
WO2023126076A1 (en) | 2022-01-03 | 2023-07-06 | Laboratorio Farmaceutico C.T. S.R.L. | Medical use of an amide of y-hydroxybutyric acid in the treatment of fragile x syndrome |
US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3940258A (en) * | 1971-11-26 | 1976-02-24 | Gaf Corporation | Method for controlling aquatic weeds with N-phenylalkyl-γ-hydroxybutyramide |
JPS6016432B2 (ja) * | 1977-07-26 | 1985-04-25 | グレラン製薬株式会社 | 複素環式化合物類およびその製造法 |
ES2052619T3 (es) * | 1987-02-23 | 1994-07-16 | Ono Pharmaceutical Co | Un procedimiento para la preparacion de los nuevos derivados de tiazolidina. |
IT1217783B (it) * | 1988-06-03 | 1990-03-30 | Farmaceutico Ct S R L Lab | Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative |
IT1248588B (it) * | 1991-06-28 | 1995-01-19 | Gaetano Crepaldi | Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari. |
JPH10501238A (ja) * | 1994-06-01 | 1998-02-03 | アリス ファーマシューティカル コーポレイション | 肥満細胞媒介症状を治療するための組成物及び方法 |
AU712467B2 (en) * | 1995-09-18 | 1999-11-04 | Sankyo Company Limited | New urea derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use |
US6455528B1 (en) * | 1997-10-14 | 2002-09-24 | Mitsubishi Pharma Corporation | Piperazine compounds and medicinal use thereof |
-
1996
- 1996-08-09 IT IT96MI001732A patent/IT1283782B1/it active IP Right Grant
-
1997
- 1997-08-07 AT AT97941921T patent/ATE215065T1/de active
- 1997-08-07 DE DE69711411T patent/DE69711411T2/de not_active Expired - Lifetime
- 1997-08-07 AU AU43790/97A patent/AU4379097A/en not_active Abandoned
- 1997-08-07 US US09/242,048 patent/US6436998B1/en not_active Expired - Lifetime
- 1997-08-07 WO PCT/EP1997/004309 patent/WO1998006690A1/en active IP Right Grant
- 1997-08-07 ES ES97941921T patent/ES2174287T3/es not_active Expired - Lifetime
- 1997-08-07 JP JP50937298A patent/JP4259615B2/ja not_active Expired - Lifetime
- 1997-08-07 PT PT97941921T patent/PT932597E/pt unknown
- 1997-08-07 CA CA002263328A patent/CA2263328C/en not_active Expired - Lifetime
- 1997-08-07 EP EP97941921A patent/EP0932597B1/en not_active Expired - Lifetime
- 1997-08-07 DK DK97941921T patent/DK0932597T3/da active
- 1997-08-07 HU HU9902437A patent/HU228595B1/hu unknown
-
2001
- 2001-12-11 US US10/013,971 patent/US6770784B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0932597A1 (en) | 1999-08-04 |
HUP9902437A2 (hu) | 1999-12-28 |
DK0932597T3 (da) | 2002-06-24 |
US6770784B2 (en) | 2004-08-03 |
WO1998006690A1 (en) | 1998-02-19 |
ATE215065T1 (de) | 2002-04-15 |
JP2000516225A (ja) | 2000-12-05 |
HU228595B1 (en) | 2013-04-29 |
DE69711411D1 (de) | 2002-05-02 |
JP4259615B2 (ja) | 2009-04-30 |
US20020165224A1 (en) | 2002-11-07 |
EP0932597B1 (en) | 2002-03-27 |
US6436998B1 (en) | 2002-08-20 |
HUP9902437A3 (en) | 2001-07-30 |
ITMI961732A0 (es) | 1996-08-09 |
ITMI961732A1 (it) | 1998-02-09 |
PT932597E (pt) | 2002-09-30 |
CA2263328C (en) | 2006-07-25 |
CA2263328A1 (en) | 1998-02-19 |
DE69711411T2 (de) | 2002-11-07 |
IT1283782B1 (it) | 1998-04-30 |
AU4379097A (en) | 1998-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2174287T3 (es) | Empleo de las amidas del acido gamma-hidroxibutarico en el tratamiento de drogadicciones y en particular del alcoholismo. | |
HN1999000124A (es) | Derivados de pirazol substituido. | |
AR015257A1 (es) | UNA COMPOSICION ACIDIFICADA Y EL USO DE DICHA COMPOSICION PARA LA MANUFACTURA DE UN MEDICAMENTO PARA EL TRATAMIENTO ToPICO DE CONDICIONES DE LAS UNAS Y DE LA PIEL | |
BR9807995A (pt) | Derivados de 1,5-diidro-pirazol(3,4-d)-pirimidinona | |
CL2004000257A1 (es) | Compuestos heterociclil-3-sulfonilaza-indol o -indazol; su composicion farmaceutica; su procedimiento de preparacion; y su uso en el tratamiento de trastornos por deficit atencional, abstinencia producto de la adiccion a drogas, alcohol o nicotina, e | |
CR6735A (es) | Substituted arylpyrazines | |
DOP2005000251A (es) | 3-amino-pirazol [3,4b] piridinas como inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento. | |
EP1333032A4 (en) | METHOD FOR PURIFYING ANTIBODIES | |
AR037109A1 (es) | Uso de flibanserina | |
SV2002000776A (es) | Nuevas imidazotriazinonas sustituidas ref.lea 34 985-sv | |
YU1097A (sh) | 2-okso i 2-tio-1,2-dihidrohinolinil-oksazolidinoni | |
MXPA03000188A (es) | Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales. | |
BR9710560B1 (pt) | Composição farmacêutica contendo clopidogrel e sinvastatina, bem como seus usos. | |
HN2002000365A (es) | Lactamas como antagonistas de taquiquininas | |
BR0114903A (pt) | 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação | |
BR0110832A (pt) | Bebida estável ao ambiente, e, método para a preparação de uma bebida a base de chá estável ao ambiente adequada para enchimento a frio | |
ES2178761T3 (es) | Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas. | |
AR030662A1 (es) | Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos | |
ES2062145T3 (es) | 1,8-naftiridinas substituidas. | |
ATE252844T1 (de) | Zusammengesetztes, essbares produkt aus mindestens drei getrennten teilen | |
AR023199A1 (es) | Solucion acuosa estable de em12, y procedimiento de preparacion de dicha solucion | |
SV2002000355A (es) | Aril- y heteroarilsulfonatos ref. lea 34321-sv | |
ES2144857T3 (es) | Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso. | |
FI901391A0 (fi) | Substituerade bifenyler. | |
AR023709A1 (es) | Semihidrocloruro del acido 8-ciano-1-ciclopropil-7-(1s, 6s-2,8-diazabiciclo[4.3.0]-nonan-8-il)-6-fluor-1,4-dihidro-4-oxo-3-quinolincarboxilico, procedimiento para su obtencion, medicamento, empleo de los mismos para la obtencion de medicamentos antibacterianos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 932597 Country of ref document: ES |